These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24527971)

  • 1. Stigma and its determinants among male drug dependents receiving methadone maintenance treatment.
    Etesam F; Assarian F; Hosseini H; Ghoreishi FS
    Arch Iran Med; 2014 Feb; 17(2):108-14. PubMed ID: 24527971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
    Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
    Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
    Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stigmatization among methadone maintenance treatment patients in mountainous areas in northern Vietnam.
    Van Nguyen H; Nguyen HL; Mai HT; Le HQ; Tran BX; Hoang CD; Le HT; Nguyen CT; Tran TD; Latkin CA; Vu TM
    Harm Reduct J; 2017 Jan; 14(1):1. PubMed ID: 28056990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone as social control: institutionalized stigma and the prospect of recovery.
    Harris J; McElrath K
    Qual Health Res; 2012 Jun; 22(6):810-24. PubMed ID: 22232295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Iranian women seeking drug treatment.
    Dolan K; Salimi S; Nassirimanesh B; Mohsenifar S; Allsop D; Mokri A
    J Womens Health (Larchmt); 2011 Nov; 20(11):1687-91. PubMed ID: 21905877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
    Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of high-risk sexual behaviors for human immunodeficiency virus infection among Iranian drug abusers.
    Keshtkar A; Majdzadeh R; Nedjat S; Gholipour M; Badakhshan A; Qorbani M; Vakili M; Salari H
    J Addict Med; 2012 Jun; 6(2):153-8. PubMed ID: 22475984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
    Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
    Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor structure, internal reliability and construct validity of the Methadone Maintenance Treatment Stigma Mechanisms Scale (MMT-SMS).
    Smith LR; Mittal ML; Wagner K; Copenhaver MM; Cunningham CO; Earnshaw VA
    Addiction; 2020 Feb; 115(2):354-367. PubMed ID: 31478272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical mismanagement in public methadone programs.
    Blansfield HN
    Conn Med; 1994 Mar; 58(3):161-4. PubMed ID: 8039380
    [No Abstract]   [Full Text] [Related]  

  • 13. Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
    Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
    Am J Drug Alcohol Abuse; 2012 May; 38(3):213-9. PubMed ID: 22352836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for maintenance pharmacotherapy of opiate dependence.
    Kreek MJ
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
    Farnia M; Ebrahimi B; Shams A; Zamani S
    Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.
    Karow A; Reimer J; Schäfer I; Krausz M; Haasen C; Verthein U
    Drug Alcohol Depend; 2010 Dec; 112(3):209-15. PubMed ID: 20728288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of the severity of depressive symptoms among intravenous heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
    Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
    Psychol Addict Behav; 2012 Mar; 26(1):145-50. PubMed ID: 21859169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone maintenance and recovery from opioid dependence.
    Maddux JF; Desmond DP
    Am J Drug Alcohol Abuse; 1992; 18(1):63-74. PubMed ID: 1562007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.